相似文献
1
Convergence of mortality rates among patients on antiretroviral therapy in South Africa and North America.
PLoS Med. 2014 Sep 9;11(9):e1001719. doi: 10.1371/journal.pmed.1001719. eCollection 2014 Sep.
2
Mortality in patients with HIV-1 infection starting antiretroviral therapy in South Africa, Europe, or North America: a collaborative analysis of prospective studies.
PLoS Med. 2014 Sep 9;11(9):e1001718. doi: 10.1371/journal.pmed.1001718. eCollection 2014 Sep.
3
All-cause mortality after antiretroviral therapy initiation in HIV-positive women from Europe, Sub-Saharan Africa and the Americas.
AIDS. 2020 Feb 1;34(2):277-289. doi: 10.1097/QAD.0000000000002399.
4
Treatment guidelines and early loss from care for people living with HIV in Cape Town, South Africa: A retrospective cohort study.
PLoS Med. 2017 Nov 14;14(11):e1002434. doi: 10.1371/journal.pmed.1002434. eCollection 2017 Nov.
5
Risk factors associated with increased mortality among HIV infected children initiating antiretroviral therapy (ART) in South Africa.
PLoS One. 2011;6(7):e22706. doi: 10.1371/journal.pone.0022706. Epub 2011 Jul 29.
6
Mortality associated with discordant responses to antiretroviral therapy in resource-constrained settings.
J Acquir Immune Defic Syndr. 2010 Jan;53(1):70-7. doi: 10.1097/QAI.0b013e3181c22d19.
7
[Highly active antiretroviral therapy of HIV patients. ART Cohort Collaboration].
Internist (Berl). 2003 Dec;44(12):1597-600. doi: 10.1007/s00108-003-1097-z.
8
Mortality and loss to follow-up among HAART initiators in rural South Africa.
Trans R Soc Trop Med Hyg. 2009 Jun;103(6):588-93. doi: 10.1016/j.trstmh.2008.10.001. Epub 2008 Nov 13.
9
Declines in mortality rates and changes in causes of death in HIV-1-infected children during the HAART era.
J Acquir Immune Defic Syndr. 2010 Jan;53(1):86-94. doi: 10.1097/QAI.0b013e3181b9869f.
10
The changing landscape of HIV-related lung disease in the era of highly active antiretroviral therapy.
Chest. 2002 Sep;122(3):768-71. doi: 10.1378/chest.122.3.768.
引用本文的文献
1
The future of global health education: training for equity in global health.
BMC Med Educ. 2016 Nov 21;16(1):296. doi: 10.1186/s12909-016-0820-0.
2
A Vision for Global Cancer Medicine: Pursuing the Equity of Chance.
J Clin Oncol. 2016 Jan 1;34(1):3-5. doi: 10.1200/JCO.2015.62.4395. Epub 2015 Nov 17.
本文引用的文献
1
Mortality in patients with HIV-1 infection starting antiretroviral therapy in South Africa, Europe, or North America: a collaborative analysis of prospective studies.
PLoS Med. 2014 Sep 9;11(9):e1001718. doi: 10.1371/journal.pmed.1001718. eCollection 2014 Sep.
2
Shattuck Lecture. Chronic infectious disease and the future of health care delivery.
N Engl J Med. 2013 Dec 19;369(25):2424-36. doi: 10.1056/NEJMsa1310472.
3
Global health 2035: a world converging within a generation.
Lancet. 2013 Dec 7;382(9908):1898-955. doi: 10.1016/S0140-6736(13)62105-4. Epub 2013 Dec 3.
4
Shared learning in an interconnected world: innovations to advance global health equity.
Global Health. 2013 Aug 30;9:37. doi: 10.1186/1744-8603-9-37.
5
Increases in adult life expectancy in rural South Africa: valuing the scale-up of HIV treatment.
Science. 2013 Feb 22;339(6122):961-5. doi: 10.1126/science.1230413.
6
Vital signs: HIV prevention through care and treatment--United States.
MMWR Morb Mortal Wkly Rep. 2011 Dec 2;60(47):1618-23.
7
Diminishing availability of publicly funded slots for antiretroviral initiation among HIV-infected ART-eligible patients in Uganda.
PLoS One. 2010 Nov 24;5(11):e14098. doi: 10.1371/journal.pone.0014098.
8
The role of social capital in successful adherence to antiretroviral therapy in Africa.
PLoS Med. 2009 Jan 27;6(1):e18. doi: 10.1371/journal.pmed.1000018.
9
Hunger, waiting time and transport costs: time to confront challenges to ART adherence in Africa.
AIDS Care. 2007 May;19(5):658-65. doi: 10.1080/09540120701244943.
10
Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis.
JAMA. 2006 Aug 9;296(6):679-90. doi: 10.1001/jama.296.6.679.
Zotero 插件